Phenotypic, genotypic, and molecular characterization of epidemic strain C10682. (A) Comparison of pulsotype and other molecular typing features of clinical isolates harboring SCCmecC10682, with previously reported prototypic SCCmec type strains (types I to VI, including subtypes IVa to IVd), the major epidemic MRSA strains in Canada (strains CMRSA1 to CMRSA10) and the United States (strains USA100 to USA800), as well as the early MRSA strains (isolated from England in the early 1960s) NCTC10442 and COL. PFGE, pulsed-field gel electrophoresis; PVL, Panton-Valentine leukocidin (+, positive; −, negative); agr, accessory gene regulator; NT, nontypeable. (B) Phenotypic and virulence gene profiles of four isolates harboring SCCmecC10682 in comparison to the early MRSA strains NCTC10442 and COL. Exotoxin genes are as follows: sea, seb, sec, sed, see, seg, seh, sei, sej, sek, and seq, staphylococcal enterotoxin A, B, C, D, E, G, H, I, J, K, and Q genes; tst, toxic shock syndrome toxin gene; eta and etb, exfoliative toxin genes A and B; chp, chemotaxis inhibitory protein gene; scn, staphylococcal complement inhibitory protein gene; hla, hlb, hld, and hlg, alpha, beta, delta, and gamma toxin genes. Adhesin genes are as follows: clfA, clumping factor gene; fnbA and fnbB, fibronectin adhesive molecule A and B genes; cna, collagen adhesive molecule gene; sdrC, sdrD, and sdrE, putative adhesin C, D, and E genes; bbp, bone sialoprotein adhesin; ebpS, elastin adhesin; map (eap), major histocompatibility complex class II analogue protein gene; ica, polysaccharide intercellular adhesin gene. Exoenzyme genes are as follows: coa, coagulase gene; V8, serine protease gene; hysA, hyaluronidase gene; sak, staphylokinase gene. S, susceptible; R, resistant; I, intermediate resistant; +, positive; −, negative; TMX-SMX, trimethoprim-sulfamethoxazole.